Literature DB >> 2452035

Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms.

J R McEwan1, N Benjamin, S Larkin, R W Fuller, C T Dollery, I MacIntyre.   

Abstract

A comparison has been made of the effects of the potent vasodilating peptide calcitonin gene-related peptide (CGRP) and substance P (SP) on resistance and capacitance vessels of normal subjects. Brachial artery infusion of 1.25 to 10 pmol/min CGRP and of 0.25 to 1.5 pmol/min SP produced maximal increases in forearm blood flow (177 +/- 75% and 198 +/- 50%, respectively), as measured by venous occlusion plethysmography. The vasodilation due to CGRP was prolonged, with a half-life of biological effect of approximately 18 min, while that due to SP was of short duration, with a half-life of biological effect of approximately 15 sec. There was rapid development of tachyphylaxis to the effects of arterial infusion of SP, but not of CGRP, during a prolonged infusion at one dose. CGRP did not alter the diameter of a superficial hand vein, either at rest or when the vein was constricted by a simultaneous infusion of norepinephrine or by the single deep breath reflex. In contrast, SP caused dilatation of veins preconstricted with norepinephrine, although the effect was only transient and dose-response curves could not be constructed. The venoconstrictor response to a single deep breath was abolished by SP. Simultaneous arterial infusion of both peptides produced at least additive, and possibly synergistic, effects on forearm blood flow. We propose that both CGRP and SP have a role in the regulation of vascular smooth muscle tone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452035     DOI: 10.1161/01.cir.77.5.1072

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  Calcitonin gene-related peptide in rat arterial and venous vessels: sensitivity to capsaicin, bradykinin and FMLP.

Authors:  E Del Bianco; F Perretti; M Tramontana; S Manzini; P Geppetti
Journal:  Agents Actions       Date:  1991-11

2.  Cutaneous blood flow responses in the forearms of Raynaud's patients induced by local cooling and intradermal injections of CGRP and histamine.

Authors:  S D Brain; R G Petty; J D Lewis; T J Williams
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

Review 3.  Role of potassium channels in the modulation of insulin release.

Authors:  P Smits
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

4.  The demonstration of vasodilator activity of pancreatic amylin amide in the rabbit.

Authors:  S D Brain; S Wimalawansa; I MacIntyre; T J Williams
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

5.  Splanchnic and cerebral vasodilatory effects of calcitonin gene-related peptide I in humans.

Authors:  M W Mulholland; M S Sarpa; J Delvalle; L M Messina
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

Review 6.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

7.  Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography.

Authors:  Floris H M Vanmolkot; Jan N J M de Hoon
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

8.  Facilitating laser Doppler measurements of cutaneous adrenergic vasoconstriction: a comparison of methods.

Authors:  D M Lipnicki; P D Drummond
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

9.  Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo.

Authors:  M Wolzt; W Gerschlager; B Zweytick; B Jilma; H Riemer; K Sertl; H G Eichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

10.  Effects of serotonin and noradrenaline on superficial hand veins in patients with primary hypertension and in healthy volunteers.

Authors:  M Wolzt; E Schmidt; B Wagner; S Schuller-Petrovic; P A Kyrle; H G Eichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.